Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research



Rating:

Share or cite this content

Citations should be made in the following way:
G. Dick (Newcastle upon Tyne, United Kingdom), S. Bourke (Newcastle upon Tyne, United Kingdom), C. Echevarria (Newcastle upon Tyne, United Kingdom), S. Doe (Newcastle upon Tyne, United Kingdom). What is a NICE definition of lung disease in patients with Cystic Fibrosis and its impact on treatment?. 4621

Member's Comments

No comment yet.

Related content which might interest you: Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis? Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 LATE-BREAKING ABSTRACT: Current management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists? Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases Year: 2007 Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 Cystic fibrosis lung disease assessed by lung clearance index Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 A new gold standard for assessing CT in early CF lung disease? Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry Source: International Congress 2016 – IPF clinical Year: 2016 Childhood interstitial lung disease: A diagnostic challenge Source: International Congress 2015 – Connective tissue disorders Year: 2015 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Cystic interstitial lung disease - a rare disease? Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease Year: 2015 Annual change of LCI among patients with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Clinical value of lung clearance index (LCI) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Cystic fibrosis-related diabetes and lung disease: an update Source: Eur Respir Rev, 30 (159) 200293; 10.1183/16000617.0293-2020 Year: 2021 Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018